New PET tracer may spot hidden breast cancer lesions
NCT ID NCT06335069
First seen Oct 01, 2025 · Last updated May 23, 2026 · Updated 32 times
Summary
This pilot study tests whether a newer PET tracer, 68Ga-FAPI-46, can find more cancer spots than the standard tracer (18F-FDG) in people with ER-positive breast cancer. About 20 women with advanced or recurrent breast cancer will receive both tracers to see which one detects more tumors. The goal is to improve staging so treatment can be more accurate.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Maastricht University Medical Center+
RECRUITINGMaastricht, 5800, Netherlands
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.